Susquehanna International Group, LLP Revolution Medicines, Inc. Put Options Transaction History

Susquehanna International Group, LLP

8 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $4.44 Million - $5.77 Million	120,300 Added 132.64%	211,000 $9.56 Million
Q2 2024 Aug 15, 2024	BUY	$30.14 - $40.68 $1.37 Million - $1.84 Million	45,300 Added 99.78%	90,700 $3.52 Million
Q1 2024 May 07, 2024	SELL	$26.56 - $33.55 $528,544 - $667,645	-19,900 Reduced 30.47%	45,400 $1.46 Million
Q4 2023 Feb 14, 2024	SELL	$18.35 - $34.12 $45,875 - $85,300	-2,500 Reduced 3.69%	65,300 $1.87 Million
Q3 2023 Nov 14, 2023	BUY	$25.17 - $35.05 $825,576 - $1.15 Million	32,800 Added 93.71%	67,800 $1.88 Million
Q2 2023 Aug 11, 2023	BUY	$20.28 - $27.0 $170,352 - $226,800	8,400 Added 31.58%	35,000 $936,000
Q1 2023 May 16, 2023	BUY	$20.76 - $30.09 $10,380 - $15,045	500 Added 1.92%	26,600 $576,000
Q4 2022 Feb 14, 2023	BUY	$17.68 - $25.53 $461,448 - $666,333	26,100 New	26,100 $621,000

266

161M

260K

620K

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $3.8B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.